Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21